Medication adherence—or, more accurately, the lack thereof—is a $337 billion problem in the United States, but tactics from advocating for personal responsibility to the support system of comprehensive medication management can turn the tide.
Congressmen and their key staffers were receptive to the messages, and many said they are in fact working hard to advance legislation to increase funding, increase treatment capacity and improve access.
In spite of the Affordable Care Act and parity laws, many states’ Essential Health Benefits benchmark plans continue to fall short on coverage for addiction treatment, according to a study by the National Center on Addiction and Substance Abuse.
For behavioral health providers, the most significant provision of the new rule allows Medicaid to pay for 15 days of inpatient treatment in a facility with more than 16 beds, tempering the often bemoaned IMD exclusion.
As deinstitutionalization continues to reduce state hospital beds across the U.S., a new 22-bed inpatient unit at Swedish Ballard gives the Seattle area a community-based care facility that specializes in comorbid disorders.
Under the final rule, providers and others are in fact permitted to disclose private health information under HIPAA—without patient authorization—to the National Instant Criminal Background Check System.